Dali Pharmaceuticalco.,Ltd (603963.SS)

CNY 1.18

(0.0%)

EBITDA Summary of Dali Pharmaceuticalco.,Ltd

  • Dali Pharmaceuticalco.,Ltd's latest annual EBITDA in 2023 was 360.83 Thousand CNY , down -428.37% from previous year.
  • Dali Pharmaceuticalco.,Ltd's latest quarterly EBITDA in 2024 Q3 was -7.09 Million CNY , down -88.49% from previous quarter.
  • Dali Pharmaceuticalco.,Ltd reported an annual EBITDA of -11.7 Million CNY in 2022, down -145.87% from previous year.
  • Dali Pharmaceuticalco.,Ltd reported an annual EBITDA of -23.78 Million CNY in 2021, down -39.77% from previous year.
  • Dali Pharmaceuticalco.,Ltd reported a quarterly EBITDA of -7.09 Million CNY for 2024 Q3, down -88.49% from previous quarter.
  • Dali Pharmaceuticalco.,Ltd reported a quarterly EBITDA of -6.19 Million CNY for 2024 Q1, down -4424.51% from previous quarter.

Annual EBITDA Chart of Dali Pharmaceuticalco.,Ltd (2023 - 2012)

Historical Annual EBITDA of Dali Pharmaceuticalco.,Ltd (2023 - 2012)

Year EBITDA EBITDA Growth
2023 360.83 Thousand CNY -428.37%
2022 -11.7 Million CNY -145.87%
2021 -23.78 Million CNY -39.77%
2020 14.3 Million CNY -60.85%
2019 22.51 Million CNY -6.38%
2018 31.33 Million CNY -50.27%
2017 73.22 Million CNY -20.73%
2016 76.65 Million CNY -0.07%
2015 90.1 Million CNY -31.26%
2014 135.28 Million CNY 14.43%
2013 119.5 Million CNY 8.31%
2012 110.36 Million CNY 0.0%

Peer EBITDA Comparison of Dali Pharmaceuticalco.,Ltd

Name EBITDA EBITDA Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 3.61 Billion CNY 99.99%
Yabao Pharmaceutical Group Co., Ltd 391.76 Million CNY 99.908%
Shandong Lukang Pharmaceutical Co.,Ltd. 741.88 Million CNY 99.951%
Zhejiang Huahai Pharmaceutical Co., Ltd. 2.15 Billion CNY 99.983%
Chongqing Taiji Industry(Group) Co.,Ltd 1.6 Billion CNY 99.977%
Tasly Pharmaceutical Group Co., Ltd 1.95 Billion CNY 99.982%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 971.82 Million CNY 99.963%
Lionco Pharmaceutical Group Co.,Ltd. -90.79 Million CNY 100.397%
Joincare Pharmaceutical Group Industry Co.,Ltd. 5.01 Billion CNY 99.993%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 111.25 Million CNY 99.676%
Shanghai Haoyuan Chemexpress Co., Ltd. 275.11 Million CNY 99.869%
China Animal Husbandry Industry Co., Ltd. 677.63 Million CNY 99.947%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 743.16 Million CNY 99.951%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 1.59 Billion CNY 99.977%
Zhejiang Shengda Bio-Pharm Co., Ltd. 34.44 Million CNY 98.953%
Harbin Pharmaceutical Group Co., Ltd. 1.02 Billion CNY 99.965%
Zhejiang Medicine Co., Ltd. 1.13 Billion CNY 99.968%
HPGC Renmintongtai Pharmaceutical Corporation 474.3 Million CNY 99.924%
Humanwell Healthcare (Group) Co.,Ltd. 4.55 Billion CNY 99.992%
Ginwa Enterprise (Group) Inc. -3.67 Million CNY 109.818%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 479.02 Million CNY 99.925%
KPC Pharmaceuticals, Inc. 801.81 Million CNY 99.955%
Henan Lingrui Pharmaceutical Co., Ltd. 736.53 Million CNY 99.951%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 265.55 Million CNY 99.864%
Ningbo Menovo Pharmaceutical Co., Ltd. 155.45 Million CNY 99.768%
Nanjing Well Pharmaceutical Group Co.,Ltd. 209.72 Million CNY 99.828%
Guizhou Yibai Pharmaceutical Co., Ltd. 355.07 Million CNY 99.898%
Zhongzhu Healthcare Holding Co.,Ltd -234.13 Million CNY 100.154%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 6.45 Billion CNY 99.994%
China National Medicines Corporation Ltd. 2.82 Billion CNY 99.987%
Shenzhen Chipscreen Biosciences Co., Ltd. 187.43 Million CNY 99.807%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 186.48 Million CNY 99.807%
Jianmin Pharmaceutical Group Co.,Ltd. 615.11 Million CNY 99.941%
Beijing Tongrentang Co., Ltd 4.09 Billion CNY 99.991%
North China Pharmaceutical Company Ltd. 1.51 Billion CNY 99.976%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 2.21 Billion CNY 99.984%
CanSino Biologics Inc. -1.64 Billion CNY 100.022%
Zhejiang Hisun Pharmaceutical Co., Ltd. 1.18 Billion CNY 99.969%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 840.85 Million CNY 99.957%
ChengDu ShengNuo Biotec Co.,Ltd. 121.76 Million CNY 99.704%
Tibet Weixinkang Medicine Co., Ltd. 266.6 Million CNY 99.865%
Changchun BCHT Biotechnology Co. 662.93 Million CNY 99.946%
Shanghai Jiaoda Onlly Co.,Ltd 17.57 Million CNY 97.947%
Jiang Zhong Pharmaceutical Co.,Ltd 1.03 Billion CNY 99.965%
Mayinglong Pharmaceutical Group Co., LTD. 633.25 Million CNY 99.943%
Cisen Pharmaceutical Co., Ltd. 840.03 Million CNY 99.957%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 267.44 Million CNY 99.865%
Hunan Warrant Pharmaceutical Co.,Ltd 292.03 Million CNY 99.876%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 5.55 Billion CNY 99.994%
Hunan Fangsheng Pharmaceutical Co., Ltd. 310.08 Million CNY 99.884%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 348.84 Million CNY 99.897%
Guobang Pharma Ltd. 1.04 Billion CNY 99.965%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 3.22 Million CNY 88.828%
Shandong Buchang Pharmaceuticals Co., Ltd. 1.09 Billion CNY 99.967%
Zhejiang Starry Pharmaceutical Co.,Ltd. 327.5 Million CNY 99.89%
Kangmei Pharmaceutical Co., Ltd. 536.71 Million CNY 99.933%
Henan Taloph Pharmaceutical Stock Co.,Ltd 111.8 Million CNY 99.677%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 565.74 Million CNY 99.936%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd -57.84 Million CNY 100.624%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 250.5 Million CNY 99.856%
Shanghai Shyndec Pharmaceutical Co., Ltd. 1.97 Billion CNY 99.982%
Shanghai Yizhong Pharmaceutical Co., Ltd. 195.4 Million CNY 99.815%
Tibet Rhodiola Pharmaceutical Holding Co. 976.16 Million CNY 99.963%
Sichuan Huiyu Pharmaceutical Co., Ltd. 203.49 Million CNY 99.823%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 259.87 Million CNY 99.861%